Analyst · Assembly Biosciences, Inc. (ASMB) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy4 analysts

Buy

Updated Aug 23, 2026

Total Analysts4

Buy

6

Hold

5

Ratings

Updated Aug 23, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$34.10

Median Target+26.85%

$43.25

Potential upside vs current price

Current Stock Price

$34.10

Median Target+26.85%

$43.25

Potential upside vs current price

Analyst Consensus

Buy4 analysts

Buy

Updated Aug 23, 2026

Total Analysts4

Buy

6

Hold

5

Ratings

Updated Aug 23, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$34.10

Median Target+26.85%

$43.25

Potential upside vs current price

Current Stock Price

$34.10

Median Target+26.85%

$43.25

Potential upside vs current price